Cargando…
COVID-19 vaccination roll-outs in eleven small countries within the WHO European region; Lessons learned
The development and administration of COVID-19 vaccines has been an essential element in controlling the COVID-19 pandemic. However, countries worldwide have faced challenges in planning and implementing vaccination strategies. The aim of the current paper is to describe the situation faced by small...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541336/ https://www.ncbi.nlm.nih.gov/pubmed/36211689 http://dx.doi.org/10.3389/fpubh.2022.959227 |
_version_ | 1784803901661249536 |
---|---|
author | Palmer, Katie Nemer, Leda Datta, Siddhartha Sankar Menne, Bettina Maria |
author_facet | Palmer, Katie Nemer, Leda Datta, Siddhartha Sankar Menne, Bettina Maria |
author_sort | Palmer, Katie |
collection | PubMed |
description | The development and administration of COVID-19 vaccines has been an essential element in controlling the COVID-19 pandemic. However, countries worldwide have faced challenges in planning and implementing vaccination strategies. The aim of the current paper is to describe the situation faced by small countries in the WHO European Region in implementing their national vaccination strategies during the first stages of the planned roll-out (up to May 2021). This paper uses information from the WHO Small Countries Initiative (SCI), which includes a network of 11 countries with populations of ≤ 2 million (Andorra, Cyprus, Estonia, Iceland, Latvia, Luxembourg, Malta, Monaco, Montenegro, San Marino, and Slovenia). The SCI countries faced many challenges including: a lack of appropriate vaccination centers, adequate workforce, and registration/booking systems to cope with the unprecedented vaccine storage and administration demands; difficulties for high-risk groups (e.g., older individuals and those with health problems or cognitive impairment) to access vaccination sites or use digital registration/booking systems; vaccine wastage due to canceled appointments; and inequalities in vaccine uptake. Innovative programmatic interventions were implemented to facilitate the vaccination uptake of the populations such as: the creation of non-medical vaccination sites and mobile vaccination units; on-site vaccination of people in long-term residential facilities and long-term medical wards; diversifying health workforce like redeployment of healthcare professionals and use of medical students and retired medical professionals; campaigns with clear information to the general public (in multiple languages where necessary) both offline and online; use of digital registration/booking systems and alternative (non-digital) registration/booking systems for relevant individuals; and administration of excess vaccine doses to non-priority groups to avoid wastage. |
format | Online Article Text |
id | pubmed-9541336 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95413362022-10-08 COVID-19 vaccination roll-outs in eleven small countries within the WHO European region; Lessons learned Palmer, Katie Nemer, Leda Datta, Siddhartha Sankar Menne, Bettina Maria Front Public Health Public Health The development and administration of COVID-19 vaccines has been an essential element in controlling the COVID-19 pandemic. However, countries worldwide have faced challenges in planning and implementing vaccination strategies. The aim of the current paper is to describe the situation faced by small countries in the WHO European Region in implementing their national vaccination strategies during the first stages of the planned roll-out (up to May 2021). This paper uses information from the WHO Small Countries Initiative (SCI), which includes a network of 11 countries with populations of ≤ 2 million (Andorra, Cyprus, Estonia, Iceland, Latvia, Luxembourg, Malta, Monaco, Montenegro, San Marino, and Slovenia). The SCI countries faced many challenges including: a lack of appropriate vaccination centers, adequate workforce, and registration/booking systems to cope with the unprecedented vaccine storage and administration demands; difficulties for high-risk groups (e.g., older individuals and those with health problems or cognitive impairment) to access vaccination sites or use digital registration/booking systems; vaccine wastage due to canceled appointments; and inequalities in vaccine uptake. Innovative programmatic interventions were implemented to facilitate the vaccination uptake of the populations such as: the creation of non-medical vaccination sites and mobile vaccination units; on-site vaccination of people in long-term residential facilities and long-term medical wards; diversifying health workforce like redeployment of healthcare professionals and use of medical students and retired medical professionals; campaigns with clear information to the general public (in multiple languages where necessary) both offline and online; use of digital registration/booking systems and alternative (non-digital) registration/booking systems for relevant individuals; and administration of excess vaccine doses to non-priority groups to avoid wastage. Frontiers Media S.A. 2022-08-18 /pmc/articles/PMC9541336/ /pubmed/36211689 http://dx.doi.org/10.3389/fpubh.2022.959227 Text en Copyright © World Health Organization 2022. Licensee Frontiers Media SA. https://creativecommons.org/licenses/by/3.0/igo/This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode (https://creativecommons.org/licenses/by/3.0/igo/) ), which permits unrestricted use, adaptation (including derivative works), distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction or adaptation of this article there should not be any suggestion that WHO or this article endorse any specific organisation or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. |
spellingShingle | Public Health Palmer, Katie Nemer, Leda Datta, Siddhartha Sankar Menne, Bettina Maria COVID-19 vaccination roll-outs in eleven small countries within the WHO European region; Lessons learned |
title | COVID-19 vaccination roll-outs in eleven small countries within the WHO European region; Lessons learned |
title_full | COVID-19 vaccination roll-outs in eleven small countries within the WHO European region; Lessons learned |
title_fullStr | COVID-19 vaccination roll-outs in eleven small countries within the WHO European region; Lessons learned |
title_full_unstemmed | COVID-19 vaccination roll-outs in eleven small countries within the WHO European region; Lessons learned |
title_short | COVID-19 vaccination roll-outs in eleven small countries within the WHO European region; Lessons learned |
title_sort | covid-19 vaccination roll-outs in eleven small countries within the who european region; lessons learned |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541336/ https://www.ncbi.nlm.nih.gov/pubmed/36211689 http://dx.doi.org/10.3389/fpubh.2022.959227 |
work_keys_str_mv | AT palmerkatie covid19vaccinationrolloutsinelevensmallcountrieswithinthewhoeuropeanregionlessonslearned AT nemerleda covid19vaccinationrolloutsinelevensmallcountrieswithinthewhoeuropeanregionlessonslearned AT dattasiddharthasankar covid19vaccinationrolloutsinelevensmallcountrieswithinthewhoeuropeanregionlessonslearned AT mennebettinamaria covid19vaccinationrolloutsinelevensmallcountrieswithinthewhoeuropeanregionlessonslearned |